- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Gastroenterology Research and Practice
Volume 2012 (2012), Article ID 214102, 6 pages
Probiotics, Symptoms, and Gut Microbiota: What Are the Relations? A Randomized Controlled Trial in Subjects with Irritable Bowel Syndrome
1Department of Research, Innlandet Hospital Trust, 2819 Gjøvik, Norway
2Unit for Applied Clinical Research, Department of Cancer Research and Molecular Medicine, Norwegian University of Science and Technology, 7491 Trondheim, Norway
3Department of Medicine, Østfold Hospital Trust, 1603 Fredrikstad, Norway
4Department of Medicine, Innlandet Hospital Trust, 2819 Gjøvik, Norway
5Nofima Mat AS, 1431 Ås, Norway
Received 23 March 2012; Revised 17 June 2012; Accepted 18 June 2012
Academic Editor: P. Gionchetti
Copyright © 2012 Per G. Farup et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- A. Kassinen, L. Krogius-Kurikka, H. Mäkivuokko et al., “The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects,” Gastroenterology, vol. 133, no. 1, pp. 24–33, 2007.
- M. Rajilić-Stojanović, E. Biagi, H. G. H. J. Heilig et al., “Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome,” Gastroenterology, vol. 141, no. 5, pp. 1792–1801, 2011.
- G. C. Parkes, N. B. Rayment, B. N. Hudspith et al., “Distinct microbial populations exist in the mucosa-associated microbiota of sub-groups of irritable bowel syndrome,” Neurogastroenterology and Motility, vol. 24, no. 1, pp. 31–39, 2012.
- C. Codling, L. O'Mahony, F. Shanahan, E. M. M. Quigley, and J. R. Marchesi, “A molecular analysis of fecal and mucosal bacterial communities in irritable bowel syndrome,” Digestive Diseases and Sciences, vol. 55, no. 2, pp. 392–397, 2010.
- K. Kajander, K. Hatakka, T. Poussa, M. Färkkilä, and R. Korpela, “A probiotic mixture alleviates symptoms in irritable bowel syndrome patients: a controlled 6-month intervention,” Alimentary Pharmacology and Therapeutics, vol. 22, no. 5, pp. 387–394, 2005.
- S. C. Ligaarden, L. Axelsson, K. Naterstad, S. Lydersen, and P. G. Farup, “A candidate probiotic with unfavourable effects in subjects with irritable bowel syndrome: a randomised controlled trial,” BMC Gastroenterology, vol. 10, article 16, 2010.
- P. Moayyedi, A. C. Ford, N. J. Talley et al., “The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review,” Gut, vol. 59, no. 3, pp. 325–332, 2010.
- N. Hoveyda, C. Heneghan, K. R. Mahtani, R. Perera, N. Roberts, and P. Glasziou, “A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome,” BMC Gastroenterology, vol. 9, article 15, 2009.
- G. Clarke, J. F. Cryan, T. G. Dinan, and E. M. Quigley, “Review article: probiotics for the treatment of irritable bowel syndrome—focus on lactic acid bacteria,” Alimentary Pharmacology and Therapeutics, vol. 35, no. 4, pp. 403–413, 2012.
- B. J. Lee and Y.-T. Bak, “Irritable bowel syndrome, gut microbiota and probiotics,” Journal of Neurogastroenterology and Motility, vol. 17, no. 3, pp. 252–266, 2011.
- G. C. Parkes, J. Brostoff, K. Whelan, and J. D. Sanderson, “Gastrointestinal microbiota in irritable bowel syndrome: their role in its pathogenesis and treatment,” American Journal of Gastroenterology, vol. 103, no. 6, pp. 1557–1567, 2008.
- R. Spiller, “Review article: probiotics and prebiotics in irritable bowel syndrome,” Alimentary Pharmacology and Therapeutics, vol. 28, no. 4, pp. 385–396, 2008.
- C. Reiff and D. Kelly, “Inflammatory bowel disease, gut bacteria and probiotic therapy,” International Journal of Medical Microbiology, vol. 300, no. 1, pp. 25–33, 2010.
- J. Sun and S. S. Yoon, “Probiotics, nuclear receptor signaling, and anti-inflammatory pathways,” Gastroenterology Research and Practice, vol. 2011, Article ID 971938, 16 pages, 2011.
- B. Skånseng, M. Kaldhusdal, and K. Rudi, “Comparison of chicken gut colonisation by the pathogens Campylobacter jejuni and Clostridium perfringens by real-time quantitative PCR,” Molecular and Cellular Probes, vol. 20, no. 5, pp. 269–279, 2006.
- P. Trosvik, B. Skånseng, K. S. Jakobsen, N. C. Stenseth, T. Næs, and K. Rudi, “Multivariate analysis of complex DNA sequence electropherograms for high-throughput quantitative analysis of mixed microbial populations,” Applied and Environmental Microbiology, vol. 73, no. 15, pp. 4975–4983, 2007.
- M. Zimonja, K. Rudi, P. Trosvik, and T. Næs, “Multivariate curve resolution of mixed bacterial DNA sequence spectra: identification and quantification of bacteria in undefined mixture samples,” Journal of Chemometrics, vol. 22, no. 5, pp. 309–322, 2008.
- Z. X. Chu, H. Q. Chen, Y. L. Ma et al., “Lactobacillus plantarum prevents the upregulation of adhesion molecule expression in an experimental colitis model,” Digestive Diseases and Sciences, vol. 55, no. 9, pp. 2505–2513, 2010.
- H. Q. Chen, J. Yang, M. Zhang et al., “Lactobacillus plantarum ameliorates colonic epithelial barrier dysfunction by modulating the apical junctional complex and PepT1 in IL-10 knockout mice,” American Journal of Physiology, vol. 299, no. 6, pp. G1287–G1297, 2010.
- T. D. Klingberg, M. H. Pedersen, A. Cencic, and B. B. Budde, “Application of measurements of transepithelial electrical resistance of intestinal epithelial cell monolayers to evaluate probiotic activity,” Applied and Environmental Microbiology, vol. 71, no. 11, pp. 7528–7530, 2005.
- T. D. Klingberg, L. Axelsson, K. Naterstad, D. Elsser, and B. B. Budde, “Identification of potential probiotic starter cultures for Scandinavian-type fermented sausages,” International Journal of Food Microbiology, vol. 105, no. 3, pp. 419–431, 2005.
- E. G. Zoetendal, A. Von Wright, T. Vilpponen-Salmela, K. Ben-Amor, A. D. L. Akkermans, and W. M. De Vos, “Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces,” Applied and Environmental Microbiology, vol. 68, no. 7, pp. 3401–3407, 2002.
- I. B. Jeffery, P. W. O'Toole, L. Öhman et al., “An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota,” Gut, vol. 61, no. 7, pp. 997–1006, 2012.
- K. L. E. Dear, M. Elia, and J. O. Hunter, “Do interventions which reduce colonic bacterial fermentation improve symptoms of irritable bowel syndrome?” Digestive Diseases and Sciences, vol. 50, no. 4, pp. 758–766, 2005.
- A. Lyra, L. Krogius-Kurikka, J. Nikkilä et al., “Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes,” BMC Gastroenterology, vol. 10, article 110, 2010.
- K. Kajander, E. Myllyluoma, M. Rajilić-Stojanović et al., “Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota,” Alimentary Pharmacology and Therapeutics, vol. 27, no. 1, pp. 48–57, 2008.